TG Therapeutics, Inc. (TGTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$28.39
Day's range
$29.42

TG Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/13/2026 22.25 M $739.24 M   1.85% 15.42%
STATE STREET CORP 05/15/2026 8.65 M $287.35 M   2.00% 5.99%
05/08/2026 8.27 M $274.86 M   100.00% 5.73%
05/15/2026 6.60 M $219.36 M   100.00% 4.58%
SOLEUS CAPITAL MANAGEMENT, L.P. 05/14/2026 4.03 M $133.85 M   28.35% 2.79%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 3.50 M $116.29 M   2.82% 2.43%
CLEARBRIDGE INVESTMENTS, LLC 05/13/2026 3.21 M $106.67 M   -6.88% 2.22%
GOLDMAN SACHS GROUP INC 05/15/2026 2.29 M $76.00 M   11.53% 1.59%
CONGRESS ASSET MANAGEMENT CO /MA 04/14/2026 2.17 M $72.02 M   12.78% 1.50%
JANE STREET GROUP, LLC 05/12/2026 2.04 M $67.82 M   110.49% 1.41%
CITADEL ADVISORS LLC 05/15/2026 1.92 M $63.88 M   90.19% 1.33%
PICTET ASSET MANAGEMENT HOLDING SA 04/22/2026 1.75 M $58.05 M   19.60% 1.21%
HOOD RIVER CAPITAL MANAGEMENT LLC 05/15/2026 1.57 M $52.13 M   -0.76% 1.09%
TWO SIGMA INVESTMENTS, LP 05/15/2026 1.54 M $51.24 M   45.44% 1.07%
BANK OF AMERICA CORP /DE/ 05/18/2026 1.46 M $48.54 M   71.69% 1.01%
NUVEEN, LLC 04/30/2026 1.45 M $48.07 M   51.81% 1.00%
NORTHERN TRUST CORP 05/14/2026 1.44 M $47.92 M   1.62% 1.00%
MORGAN STANLEY 05/15/2026 1.41 M $46.78 M   -6.31% 0.98%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 1.30 M $43.02 M   -1.27% 0.90%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 1.08 M $36.03 M   129.46% 0.75%
JANE STREET GROUP, LLC 05/12/2026 995.30 K $33.06 M   44.39% 0.69%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 979.90 K $32.55 M   -7.25% 0.68%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 968.67 K $32.18 M   100.00% 0.67%
BNP PARIBAS ARBITRAGE, SNC 05/12/2026 957.03 K $31.79 M   39.99% 0.66%
BANK OF NEW YORK MELLON CORP 05/05/2026 887.31 K $29.48 M   -1.24% 0.61%
INVESCO LTD. 05/12/2026 720.93 K $23.95 M   -55.22% 0.50%
WOODLINE PARTNERS LP 05/15/2026 715.50 K $23.77 M   100.00% 0.50%
PRINCIPAL FINANCIAL GROUP INC 05/04/2026 665.53 K $22.11 M   -21.50% 0.46%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 632.73 K $21.02 M   4.42% 0.44%
D. E. SHAW & CO., INC. 05/15/2026 590.05 K $19.60 M   -15.75% 0.41%
683 CAPITAL MANAGEMENT, LLC 05/15/2026 590.00 K $19.60 M   63.89% 0.41%
05/15/2026 577.00 K $19.17 M   43.68% 0.40%
GOLDMAN SACHS GROUP INC 05/15/2026 550.00 K $18.27 M   100.00% 0.38%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 544.72 K $18.10 M   -38.62% 0.38%
PENN CAPITAL MANAGEMENT COMPANY, LLC 05/07/2026 541.96 K $18.05 M   0.71% 0.38%
OPALEYE MANAGEMENT INC. 05/15/2026 535.00 K $17.77 M   0.00% 0.37%
BANK OF MONTREAL /CAN/ 05/13/2026 515.33 K $17.12 M   0.58% 0.36%
SQUAREPOINT OPS LLC 05/15/2026 513.81 K $17.07 M   -39.73% 0.36%
ASSENAGON ASSET MANAGEMENT S.A. 04/20/2026 510.05 K $16.94 M   218.01% 0.35%
UBS GROUP AG 05/05/2026 505.65 K $16.80 M   -5.84% 0.35%
PUBLIC SECTOR PENSION INVESTMENT BOARD 05/13/2026 487.26 K $16.19 M   3.61% 0.34%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 467.80 K $15.54 M   -39.89% 0.32%
RAYMOND JAMES FINANCIAL INC 05/14/2026 426.38 K $14.16 M   -32.31% 0.30%
VOYA INVESTMENT MANAGEMENT LLC 05/12/2026 419.61 K $13.94 M   3.64% 0.29%
NEW YORK STATE COMMON RETIREMENT FUND 05/06/2026 401.85 K $13.35 M   7.28% 0.28%
RHUMBLINE ADVISERS 05/12/2026 385.34 K $12.80 M   1.16% 0.27%
BRAIDWELL LP 05/15/2026 358.80 K $11.92 M   100.00% 0.25%
AMERIPRISE FINANCIAL INC 05/15/2026 355.59 K $11.81 M   -1.28% 0.25%
MAN GROUP PLC 05/15/2026 354.70 K $11.78 M   -62.92% 0.25%
CITIGROUP INC 05/11/2026 353.98 K $11.76 M   -26.79% 0.25%

TG Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 477 institutional investors and hedge funds held shares of TG Therapeutics Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 22.25 M

STATE STREET CORP: 8.65 M

Soleus Capital Management, L.P.: 4.03 M

GEODE CAPITAL MANAGEMENT, LLC: 3.5 M

Clearbridge Investments, LLC: 3.21 M

GOLDMAN SACHS GROUP INC: 2.29 M

73.02% of TG Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 127.16 M shares in the last 24 months. This purchase volume represents approximately $3.71 B in transactions.